ArticleBMC infectious diseases2024

Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia.

Ee Vien Low et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.